MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 35671-35680 Newer>
The Motley Fool
April 14, 2009
Anders Bylund
I Wouldn't Dare Bet Against Google Google is not in the habit of disappointing its investors. But things might be different this time, as Google prepares for its first-quarter report. mark for My Articles 45 similar articles
The Motley Fool
April 14, 2009
Adam J. Wiederman
Why I'm Down More Than 80%, and How to Avoid My Mistakes One investor tells how he lost more than 80% last year, with the hope that you will learn from his mistakes. mark for My Articles 60 similar articles
The Motley Fool
April 14, 2009
Rick Aristotle Munarriz
4 Chinese Stocks That Have Doubled Things are picking up again in China. Take a look at these Chinese growth stocks that have doubled off their 52-week lows: Baidu... Home Inns & Hotels... China Finance Online... Shanda Interactive... mark for My Articles 214 similar articles
The Motley Fool
April 14, 2009
Tim Beyers
Palm's Pre: Dead on Arrival? A recent survey of 4,292 adult smartphone buyers by ChangeWave Research found that only 4% of respondents planned to buy the Pre in the next six months. mark for My Articles 1479 similar articles
The Motley Fool
April 14, 2009
Morgan Housel
It's Good to Be Goldman A monster quarter proves Goldman Sachs can still get it done. Quarterly earnings just destroyed analyst expectations by more than 100%. mark for My Articles 603 similar articles
The Motley Fool
April 14, 2009
Dan Caplinger
The Wrong Leaders to Follow Into the Market Active fund managers are investing in stocks again. Should you? mark for My Articles 119 similar articles
The Motley Fool
April 14, 2009
Rick Aristotle Munarriz
Has Microsoft SINA the Light? Is Microsoft really eyeing Chinese new-media darling SINA as a potential acquisition? mark for My Articles 173 similar articles
The Motley Fool
April 14, 2009
Brian Orelli
Sell Dendreon! No, Buy Dendreon! Dendreon, everyone's favorite tiny biotech, just got bigger because of positive phase 3 results for its prostate cancer treatment, Provenge. mark for My Articles 513 similar articles
The Motley Fool
April 14, 2009
James Brumley
SPX's Punishment Doesn't Fit the Crime When global infrastructure conglomerate SPX lowered its Q1 and full-year 2009 guidance, shares dropped 18%. The plunge could spell opportunity. mark for My Articles 111 similar articles
The Motley Fool
April 14, 2009
Morgan Housel
Euphoria Ignites Bank Stocks Unfortunately, exuberance alone seems to drive most of this rally. mark for My Articles 263 similar articles
<Older 35671-35680 Newer>    Return to current articles.